118 related articles for article (PubMed ID: 8506763)
1. Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease.
Verhelst J; Gerris J; Joostens M; Van der Meer S; Van Royen E; Mahler C
Gynecol Endocrinol; 1993 Mar; 7(1):49-55. PubMed ID: 8506763
[TBL] [Abstract][Full Text] [Related]
2. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.
Seyam E; Hefzy E
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():126-133. PubMed ID: 29408743
[TBL] [Abstract][Full Text] [Related]
5. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
[TBL] [Abstract][Full Text] [Related]
6. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
7. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
8. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
Burger CW; Hompes PG; Korsen TJ; Schoemaker J
Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
[TBL] [Abstract][Full Text] [Related]
9. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome.
Greenblatt E; Casper RF
Am J Obstet Gynecol; 1987 Feb; 156(2):279-85. PubMed ID: 2950757
[TBL] [Abstract][Full Text] [Related]
10. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
Al-Ojaimi EH
Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
[TBL] [Abstract][Full Text] [Related]
11. Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease.
Aakvaag A; Gjønnaess H
Br J Obstet Gynaecol; 1985 Dec; 92(12):1258-64. PubMed ID: 3936533
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.
Liguori G; Tolino A; Moccia G; Scognamiglio G; Nappi C
Gynecol Endocrinol; 1996 Aug; 10(4):257-64. PubMed ID: 8908526
[TBL] [Abstract][Full Text] [Related]
13. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
14. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
15. Endocrine changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries.
Campo S; Felli A; Lamanna MA; Barini A; Garcea N
Hum Reprod; 1993 Mar; 8(3):359-63. PubMed ID: 8473448
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome.
Godinjak Z; Javorić R
Bosn J Basic Med Sci; 2007 May; 7(2):171-5. PubMed ID: 17489756
[TBL] [Abstract][Full Text] [Related]
17. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
Polson DW; Mason HD; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
[TBL] [Abstract][Full Text] [Related]
19. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
20. Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.
Burger CW; van Kessel H; Schoemaker J
Acta Endocrinol (Copenh); 1983 Nov; 104(3):357-64. PubMed ID: 6415997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
